CRNX - Crinetics Pharmaceuticals files to sell 8.33M shares of common stock for holders March, 19 2024 04:14 PM Crinetics Pharmaceuticals Inc. 2024-03-19 16:14:34 ET More on Crinetics Pharmaceuticals Crinetics gains as late-stage trial for lead drug succeeds Crinetics reports encouraging Phase 2 data for carcinoid syndrome drug Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals For further details see: Crinetics Pharmaceuticals files to sell 8.33M shares of common stock for holders